George D. Yancopoulos

2013

In 2013, George D. Yancopoulos earned a total compensation of $31M as President, Regeneron Laboratories and Chief Scientific Officer at Regeneron Pharmaceuticals, a 62% decrease compared to previous year.

Compensation breakdown

Bonus$1,759,500
Option Awards$28,096,838
Salary$879,800
Other$281,455
Total$31,017,593

Yancopoulos received $28.1M in option awards, accounting for 91% of the total pay in 2013.

Yancopoulos also received $1.8M in bonus, $879.8K in salary and $281.5K in other compensation.

Rankings

In 2013, George D. Yancopoulos' compensation ranked 31st out of 12,286 executives tracked by ExecPay. In other words, Yancopoulos earned more than 99.7% of executives.

ClassificationRankingPercentile
All
31
out of 12,286
100th
Division
Manufacturing
7
out of 4,612
100th
Major group
Chemicals And Allied Products
4
out of 1,462
100th
Industry group
Drugs
3
out of 1,156
100th
Industry
Pharmaceutical Preparations
3
out of 890
100th
Source: SEC filing on April 26, 2016.

Yancopoulos' colleagues

We found five more compensation records of executives who worked with George D. Yancopoulos at Regeneron Pharmaceuticals in 2013.

2013

Leonard Schleifer

Regeneron Pharmaceuticals

Chief Executive Officer

2013

Neil Stahl

Regeneron Pharmaceuticals

Executive Vice President, Research & Development

2013

Robert Landry

Regeneron Pharmaceuticals

Chief Financial Officer

2013

Robert Terifay

Regeneron Pharmaceuticals

Executive Vice President, Commercial

2013

Murray Goldberg

Regeneron Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like